The Department is welcoming our new Assistant Professor Sayan Bhattacharya, who will be associated with the Division of Theory and Foundations (FoCS) and the Centre for Discrete Mathematics and its Applications (DIMAP).

Sayan obtained his PhD in Computer Science from Duke University (USA) in 2012. Then he did his postdoc at Max Planck Institute for Informatics, Saarbrücken (Germany) and at University of Vienna (Austria). From October, 2014 till February, 2017, he was a faculty member at the Institute of Mathematical Sciences, Chennai (India).

He works in theoretical computer science. Specifically, his research interests are in dynamic graph algorithms, data structures, online algorithms, streaming algorithms, and algorithmic game theory.

For more information about Sayan's research please see his web page at https://www.imsc.res.in/~bsayan/.

Dr Marcin Jurdzinski and Dr Ranko Lazic from Warwick's DIMAP inter-disciplinary centre and the Computer Science department, jointly with Dr Sven Schewe, Dr John Fearnley and Dr Dominik Wojtczak from the University of Liverpool, will lead a new research project on solving parity games in theory and practice, to run 2017-2020.

The project will be supported by approx. £750K from the EPSRC across the two sites. The proposal was ranked top at its funding prioritisation panel, and the reviewers said:

This is the strongest and best designed proposal on theoretical computer science I have seen in the last five years.

as well as

The proposal is about fundamental research, but there is a clear path connecting the expected results to concrete industrial needs on program verification and program synthesis.

Professor Artur Czumaj, head of DIMAP and of the Theory and Foundations research division, commented:

This exciting new EPSRC project builds on excellence in theoretical computer science for which Warwick is internationally renowned. It strengthens our collaborative links with Computer Science at Liverpool, who were likewise one of the leading departments for research outputs in the most recent REF.

A University of Warwick computer scientist is working with technology that could revolutionise how some cancers are diagnosed.

A high-tech computer system is able to read samples of human tissue and aid pathologists in the identification of minute changes in cells that can indicate cancer is present. More than 10,000 slides were examined in the first phase of the study[1] which shows that pathologists are as good at accurately diagnosing cancer on a computer as they are with a microscope.

Now Professor Nasir Rajpoot is working with University Hospitals Coventry and Warwickshire NHS Trust (UHCW) to develop the next generation of image analytics to use with this technology.

The ground breaking technology has the power to help pathologists grade some types of tumours, including lung, prostate and bladder tumours with precision. In prostate cancer, for example, this could make the difference between someone being offered surgery rather than drug based treatments.

The computer system known as The Omnyx® Precision Solution™, can help pathologists to see the small differences in cells in the same way that they have currently been using a microscope, allowing them to make sound decisions on many aspects of cancer diagnosis.

UHCW is the first in the UK to introduce this kind of innovation to its routine practice, meaning it is already benefitting patients.

The Omnyx system digitises slides which are traditionally placed on a microscope so that pathologists can look at them on a computer. Once on the computer, the UHCW scientists have written programmes which will separate normal from abnormal samples.

Consultant pathologist David Snead said:

“I am delighted that University Hospital, Coventry has led this ground breaking study. This provides even greater evidence that digital pathology really works, and works well. The introduction of digital pathology has fantastic potential benefits for patients. We can expect to be able to read samples more quickly than before, and the big advantage is that we can use the computer to easily manipulate an image or its data. For some patients, this additional information may change how their disease is managed.”

Mamar Gelaye, CEO of Omnyx noted:

“Dr Snead and his team have made a significant contribution to showing the value of digital pathology for both clinicians and patients. We are only at the beginning of harnessing the benefits of digitising pathology services, and we look forward to working with institutions like University Hospitals Coventry and Warwickshire NHS Trust to achieve even greater progress in delivering more accurate and efficient cancer diagnoses.”

Dr Rajpoot said:

“This is a very exciting development in the field of digital pathology. What it means is that we can now move forward with the application of digital pathology image analysis algorithms in a clinical setting. For instance, computer algorithms can automate the process of detecting normal samples so that some routine cases will not need to be looked at by a pathologist at all.

“Together with the team at UHCW, we are looking forward to developing technologies for computer-assisted diagnosis and image analytics for discovering biologically meaningful and clinically relevant signatures of cancer.”